Viridian Therapeutics
VRDN
#5423
Rank
A$1.61 B
Marketcap
$19.83
Share price
-5.22%
Change (1 day)
-19.95%
Change (1 year)

Earnings for Viridian Therapeutics (VRDN)

Earnings in 2024 (TTM): -A$0.41 Billion

According to Viridian Therapeutics's latest financial reports the company's current earnings are A$0.3 Million. a decrease over its 2023 earnings that were of -A$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viridian Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.45 Billion13.15%
2023 -A$0.4 Billion82.31%
2022 -A$0.22 Billion62.82%
2021 -A$0.14 Billion-27.89%
2020 -A$0.19 Billion168.55%
2019 -A$67.88 Million28.93%
2018 -A$52.65 Million21.82%
2017 -A$43.22 Million107.72%
2016 -A$20.81 Million12.44%
2015 -A$18.51 Million62.91%
2014 -A$11.36 Million3399.7%
2013 -A$0.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-46.46%๐Ÿ‡บ๐Ÿ‡ธ USA